Others titles

  • MedSun Adverse Events Reports
  • MD Medical Product Safety Network
  • Medical Devices Safety Network

Keywords

  • Medical Product Safety
  • Adverse Event Reporting Program
  • MedSun
  • MD Safety
  • MD Reporting

Medical Product Safety Network

The Medical Product Safety Network (MedSun) is an adverse event reporting program launched by the U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH).

Log in to download
Complexity

Get The Data

For getting access to data download links please read and accept the end-user license agreement.
Your Data License
  • Research
    Non-Commercial, Share-Alike, Attribution Free Forever
  • Commercial
    Commercial Use, Remix & Adapt, White Label Log in to download

John Snow Labs Standard End User License Agreement

Last updated:January 20, 2021

This Standard End User License Agreement (“EULA”) applies to customers of John Snow Labs Inc. (as defined below), using any product of John Snow Labs Inc. on John Snow Labs Marketplace as defined below (hereinafter referred to “you”) and John Snow Labs Inc., a Delaware corporation (“John Snow Labs”, “we” or “us”).

By downloading, installing, and/or using (as applicable) any Product of John Snow Labs (as defined below), you automatically agree to be bound by, and use our Products in compliance with, this EULA. This EULA, together with additional terms and conditions and/or policies referenced herein or located on https://www.johnsnowlabs.com and/or conveyed to you by John Snow Labs, is a legally binding contract between you and John Snow Labs.

PLEASE READ THIS EULA CAREFULLY BEFORE PURCHASING, INSTALLING OR USING OUR PRODUCTS MADE AVAILABLE ON JOHN SNOW LABS MARKETPLACE.

We may make changes to this EULA from time to time. When we do so, we will revise the “last updated” date given above. The then-current version of this EULA will supersede all earlier versions. You agree that your continued use of our Products after such changes have been published to our EULA will constitute your acceptance of such revised EULA.

Definitions

“John Snow Labs Data Library” means a data library located at https://www.johnsnowlabs.com;

“Products” means products and services of John Snow Labs that you download and use from listings in John Snow Labs Data Library;

Important Notice

By installing and using our Products, you acknowledge that the use of the Products can be subject to the restrictions and controls imposed by United States export regulations.

You represent and warrant that you do not intend to use the Products for any purpose prohibited by United States export regulations, including, without limitation, terrorism, cyber-attacks, cyber-crimes, money-laundering, industrial espionage, or nuclear, chemical or biological weapons proliferation. Further, you represent and warrant that you are not listed as a denied party on any list governing United States exports.

Eligibility

Our Products can be used by an individual, business or other legal entity, or both. If you are entering into this EULA, or using the Products, on behalf of a company or other legal entity, you represent that you have the authority to bind such entity to this EULA, in which case “you” shall refer to such entity.

In the event you have entered into a separate written agreement with John Snow Labs regarding the Products that contemplates terms that are inconsistent with this EULA, the written agreement shall control and this EULA will not apply to you to the extent inconsistent with such written agreement, or, if such written agreement is contemplated to be in lieu of this EULA, then this EULA shall not apply at all.

Your Access and Use

Subject to your compliance with this EULA, as well as any other applicable policies, John Snow Labs grants you non-exclusive, non-transferable, license to install, access to, modify, and use of, the Products worldwide (subject to applicable export laws) during the term of this EULA (as described below) solely for research, private study and personal use of Products.

This license is personal to you, and you may not resell our Products, permit other users access to our Products through your account. Your right to use our Products is limited by all terms and conditions set forth in this EULA.

Except for your pre-existing rights and this license granted to you, we and our licensors retain all rights, titles and interests in and to our Products, all related intellectual property rights, including trademarks (whether registered or pending), domain and business names. Our Products are protected by applicable intellectual property laws, including United States copyright law and international treaties.

Except for the foregoing license, you have no other rights in the Products and you may not modify, edit, copy, reproduce, create derivative works of, reverse engineer, alter, enhance or in any way exploit the Products in any manner. If you breach any of this EULA, the above license will terminate automatically.

You will be deemed to have taken any action that you permit, assist or facilitate any person or entity to take related to this EULA, your content or use of the Products. You are responsible for end users’ use of your content and the Products. You will ensure that all end users comply with your obligations under this EULA and that the terms of your agreement with each end user are consistent with this EULA. If you become aware of any violation of your obligations under this EULA caused by an end user, you will immediately suspend access to your content and the Products by such end user. We do not provide any support or services to end users unless we have a separate agreement with you or an end user obligating us to provide such support or services.

Restrictions

You will access or use our Products solely via John Snow Labs Data Library.

Except as otherwise explicitly provided in this EULA or as may be expressly permitted by applicable law, you will not, and will not permit or authorize any third party to:

  1. reproduce, modify, translate, enhance, decompile, disassemble, reverse engineer or create derivative works of any of our Products or its technological features or measures;
  2. rent, lease, sell, resell, loan, distribute, or sublicense access to any of our Products;
  3. circumvent or disable any security or technological features or measures of our Products;
  4. use our intellectual property rights without our express prior written authorization;
  5. use our Products for more than one trial period, unless the trial period is extended by John Snow Labs’ prior written permit;
  6. use our Products with an intent to build a competitive product or service, or copy or substantially copy any ideas, features, functions, organization, structure, application program interface, graphics, or user interface of the Products;
  7. store, copy, modify, distribute, or resell any of the information; audio, visual, and audiovisual works, or other content made available on our Products (collectively, “Content”) or compile or collect any Content as part of a database or other work;
  8. use any automated tool (e.g., robots, spiders) to access or use our Products, or to store, copy, modify, distribute, or resell any Content;
  9. circumvent or disable any rights management, usage rules, or other security features of our Products;
  10. use our Products in a manner that overburdens, or that threatens the integrity, performance, or availability of, our Products; or
  11. remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of our Products or any Content.

Fees and Taxes

Your use of the Products is subject to our fees. All fees are given on our website https://www.johnsnowlabs.com. Except as set forth in this EULA, the fees are non-refundable. We are entitled to revise our fees from time to time.

The fees exclude any federal, state or local taxes, VAT, GST, or similar taxes. You are responsible for identification and payment of all taxes as required by applicable law.

Term and Termination

This EULA will become effective as of the date of your order of Products and shall be in effect until terminated.

John Snow Labs may suspend or terminate your right to use our Products, if you or your end user’s use of the Products:

  1. is in breach of this EULA;
  2. poses a security risk to our Products;
  3. could adversely impact our systems, the Products or other customers;
  4. could subject us, our affiliates, or any third party to liability; or
  5. could be fraudulent.

We may also suspend or terminate your right to use our Products, if you fail to perform your payment obligations, or you have ceased to operate in the ordinary course, made an assignment for the benefit of creditors or similar disposition of your assets, or become the subject of any bankruptcy, reorganization, liquidation, dissolution or similar proceeding.

We may also suspend or terminate your right to use our Products without any reason upon a relevant 30 days’ written notice to you and will refund the unused fees pre-paid by you for access to the Products for the affected time period (if any). Where your access is suspended or terminated by the breach of this EULA or applicable laws, John Snow Labs will will not provide, or be liable for, any refund.

You will cease use of the Products during any period of suspension, or upon termination of this EULA.

All provisions which by their nature are intended to survive termination shall survive termination of this EULA.

Support

If applicable to your Product, John Snow Labs will provide you with the support services. If you use a trial access, support services are excluded. Under this EULA, our support services exclude any installation, training, maintenance services (including any error corrections, bug fixes, or new releases), technical assistance, consulting services, or other services of any kind. Such services are provided at John Snow Labs’ discretion.

From time to time John Snow Labs can perform updates to our software. If available, such updates may include bug fixes, new features and/or enhancements. You are solely responsible for deploying such updates at your own risk and liability.

Access to our Products

We do not provide you with the equipment to access our Products. You are responsible for all fees charged by third parties related to your access and use of our Products (e.g., charges by Internet service providers).

You are responsible for monitoring your use of the Products, including payment of all fees and/or taxes related to such access and use. You agree that John Snow Labs is permitted to request and you hereby consent to provide John Snow Labs information related to your use of the Products for auditing purposes.

You also certify that you are legally permitted to use the Products, and take full responsibility for the selection and use of the Products. This EULA is void where prohibited by law, and the right to use the Products is revoked in such jurisdictions. John Snow Labs makes no claim that the Products may be lawfully used outside of the United States. If you use the Products from outside of the United States, you do so at your own risk and you are responsible for compliance with the laws of jurisdiction.

Privacy Policy

We may collect, store and receive personal and other information about you through our Products. Our collection and use of this information is governed by our Privacy Policy available at https://www.JohnSnowLabs.com/privacy/ which may be amended from time to time.

Links and Third Party Content

Our Products may display, or contain links to, third party products, services, and websites. Any opinions, advice, statements, services, offers, or other information that constitutes part of the content expressed, authored, or made available by other users or other third parties, or which is accessible through or may be located using our Products (collectively, “Third Party Content”) are those of the respective authors or producers and not of us or our shareholders, directors, officers, employees, agents, or representatives.

We do not control Third Party Content and do not guarantee the accuracy, integrity or quality of such Third Party Content. We are not responsible for the performance of, we do not endorse, and we are not responsible or liable for, any Third Party Content or any information or materials advertised in any Third Party Content. By using our Products, you may be exposed to content that is offensive, indecent, or objectionable. We are not responsible or liable, directly or indirectly, for any damage or loss caused to you by your use of or reliance on any goods, services, or information available on or through any third party service or Third Party Content. It is your responsibility to evaluate the information, opinion, advice, or other content available on and through our Products.

Proprietary Rights

John Snow Labs will not obtain any rights under this EULA from you (or your licensors) to your content.

The Products, including software, is and remains the exclusive property of John Snow Labs and its licensors. Except for the access and use rights expressly set forth in this EULA, no license or other rights in or to the Products or John Snow Labs trademark(s) and other intellectual property rights therein, are granted to you, and all such licenses and rights are expressly reserved. You will not remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of our Products or any Content.

Trademarks

“John Snow Labs,” the John Snow Labs logo, and any other product, business or service name or slogan, whether registered or pending, displayed on our Products are trademarks of John Snow Labs, Inc. or its suppliers or licensors, and may not be copied, imitated or used, in whole or in part, without the prior written permission of John Snow Labs or the applicable trademark holder. You may not use any metatags or any other “hidden text” utilizing “John Snow Labs” or any other name, trademark or product, business or service name of John Snow Labs without our prior written permission. In addition, the look and feel of our Products, including all page headers, custom graphics, button icons and scripts, is the service mark, trademark and/or trade dress of John Snow Labs and may not be copied, imitated or used, in whole or in part, without our prior written permission. All other trademarks, pending trademarks, registered trademarks, product names and company names or logos mentioned in our Products are the property of John Snow Labs Inc. and/or their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, supplier, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by us.

Disclaimer of Warranties

YOUR USE OF THE PRODUCTS IS AT YOUR SOLE RISK. THE PRODUCTS AND CONTENT EACH ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS. WE AND OUR SUPPLIERS AND LICENSORS EXPRESSLY DISCLAIM ALL WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NON-INFRINGEMENT. WE DO NOT GUARANTEE THE ACCURACY, COMPLETENESS, OR USEFULNESS OF THE PRODUCTS OR ANY CONTENT, AND YOU RELY ON THE PRODUCTS AND CONTENT AT YOUR OWN RISK. ANY MATERIAL THAT YOU ACCESS OR OBTAIN THROUGH OUR PRODUCTS IS DONE AT YOUR OWN DISCRETION AND RISK AND YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OF ANY MATERIAL THROUGH OUR PRODUCTS. NO ADVICE OR INFORMATION, WHETHER ORAL OR WRITTEN, OBTAINED BY YOU FROM US OR THROUGH OR FROM OUR PRODUCTS WILL CREATE ANY WARRANTY NOT EXPRESSLY STATED IN THIS EULA. SOME STATES MAY PROHIBIT A DISCLAIMER OF WARRANTIES AND YOU MAY HAVE OTHER RIGHTS THAT VARY FROM STATE TO STATE.

Limitation of Liability

WE AND OUR SUPPLIERS AND LICENSORS WILL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES, INCLUDING BUT NOT LIMITED TO, DAMAGES FOR LOSS OF PROFITS, GOODWILL, USE, DATA, OR OTHER INTANGIBLE LOSSES (EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF THESE DAMAGES), RESULTING FROM YOUR USE OF OUR PRODUCTS AND CONTENT. UNDER NO CIRCUMSTANCES WILL THE TOTAL LIABILITY OF US AND OUR SUPPLIERS AND LICENSORS OF ALL KINDS ARISING OUT OF OR RELATED TO YOUR USE OF THE PRODUCTS AND CONTENT (INCLUDING BUT NOT LIMITED TO WARRANTY CLAIMS), REGARDLESS OF THE FORUM AND REGARDLESS OF WHETHER ANY ACTION OR CLAIM IS BASED ON CONTRACT, TORT, OR OTHERWISE, EXCEED THE AMOUNTS, IF ANY, THAT YOU HAVE PAID FOR YOUR USE OF THE PRODUCTS AND CONTENT. BECAUSE SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, THE ABOVE LIMITATION MAY NOT APPLY TO YOU.

Indemnity

To the full extent permitted by applicable law, you shall defend, indemnify and hold harmless John Snow Labs, its affiliates and its licensors, and each of their respective employees, officers, directors, and representatives from and against any claims, damages, losses, liabilities, costs, and expenses (including reasonable attorney’s fees) arising out of or relating to any third party claim concerning: (a) your use of the Products; (b) breach of this EULA or violation of applicable law by you; (c) any content or the combination of such content with other software, content or processes, including any claim involving alleged infringement or misappropriation of third-party rights by such content or combination; or (d) breach of any obligation or duty you owe to a third party.

Legal Notices

Enforcement of this EULA will be governed by the laws of the State of Delaware, excluding its conflict and choice of law principles. The exclusive jurisdiction and venue for any claims arising out of or related to this EULA or your use of the Products will lie in the state and federal courts located in Sussex County, within the State of Delaware, and you irrevocably agree to submit to the jurisdiction of such courts. Our failure to enforce any right or provision in this EULA will not constitute a waiver of such right or provision unless acknowledged and agreed by us in writing. In the event that a court of competent jurisdiction finds any provision of this EULA to be illegal, invalid, or unenforceable, the remaining provisions will remain in full force and effect.

Notifications

We may use your contact information to notify you if we have any legitimate interest or if we need to notify you on any important information related to your use of Products. We will not send you newsletters unless you expressly consented to such notifications.

Contacting Us

If you have any questions or concerns about our Products or this EULA, you may contact us by email at support@JohnSnowLabs.com.

Description

The Medical Product Safety Network dataset involves the reporting of problems with medical products from a network of approximately 300 hospitals, nursing homes and home health facilities around the United States.
MedSun sites work collaboratively with the FDA to assist in detecting, understanding, and sharing information concerning the safety of medical products. MedSun utilizes a secure, online system for reporting problems with the use of medical devices. MedSun plays a critical role in FDA’s postmarket surveillance efforts.

The primary goal for MedSun is to work collaboratively with the clinical community to identify, understand, and solve problems with the use of medical devices.
The Safe Medical Devices Act (SMDA) defines ‘user facilities’ as hospitals, nursing homes, and outpatient treatment and diagnostic centers. They are required to report medical device problems that result in serious illness, injury, or death. MedSun participants are also highly encouraged to voluntarily report problems with devices, such as ‘close-calls,’ potential for harm, and other safety concerns. By monitoring reports about problems and concerns before a more serious event occurs, FDA, manufacturers, and clinicians work together proactively to prevent serious injuries and death.

About this Dataset

Data Info

Date Created

2002

Last Modified

2024-04-04

Version

2024-04-04

Update Frequency

Daily

Temporal Coverage

2006-03-24 to 2024-04-04

Spatial Coverage

United States

Source

John Snow Labs; U.S. Food and Drug Administration (FDA);

Source License URL

Source License Requirements

N/A

Source Citation

N/A

Keywords

Medical Product Safety, Adverse Event Reporting Program, MedSun, MD Safety, MD Reporting

Other Titles

MedSun Adverse Events Reports, MD Medical Product Safety Network, Medical Devices Safety Network

Data Fields

Name Description Type Constraints
Device_BrandThe brand of medical devicestring-
Device_ManufacturerDevice manufacturer namestring-
Device_TypeThe type of medical devicestring-
Device_ProblemProblem associated with the devicestring-
Date_ReportThe Date reportdaterequired : 1
Event_DescriptionThe Event descriptionstring-

Data Preview

Device BrandDevice ManufacturerDevice TypeDevice ProblemDate ReportEvent Description
Echelon Contour Curved CutterEthicon Endo-Surgery LLCStaple implantableSerious injury2024-04-04Contour stapler failed. Stapler pushers were down - but there were no staples applied.
PRISMAFLEX SETGAMBRO INDUSTRIESDialyzer high permeability with or without sealed dialysate systemPotential for patient harm2024-04-04The patient was to start a continuous renal replacement therapy (CRRT) - and the registered nurse (RN) had attempted to start on patient and there was an issue with previous Prismaflex set. The RN set-up new Prismaflex set - and the set was connected to patient to begin therapy. The therapy was started and immediately the RN received an alarm for blood leak. The RN was able to stop therapy because the blood leak was visible in the tubing and extended to auto-effluent tubing. The patient was safely disconnected from the Prismaflex. The Prismaflex set was removed - and the Prismaflex machine was removed from service to be checked by BioMed. The patient had CRRT set-up with a new Prismaflex machine and Prismaflex set.
PRISMAFLEX SETGAMBRO INDUSTRIESDialyzer high permeability with or without sealed dialysate systemPotential for patient harm2024-04-04Continuous renal replacement therapy (CRRT) was being setup with the Baxter Prismaflex machine. The registered nurse (RN) was following the onscreen instructions to load - prime and ready system for connection to patient to begin therapy. The Prismaflex machine has four small pumps the dialysis cassette tubing wraps around. The RN was attempting to load the tubing and the tubing would not load around the dialysate pump (upper right pump). The RN stated the tubing kept getting kinked. Finally - the tubing did load around the dialysate pump. The RN proceeded to the priming step and there was an occlusion alarm on the auto effluent tubing. The RN attempted to trouble shoot and eventually unloaded cassette and started the process again with a new cassette.
CLEARLINK/CONTINU-FLOBAXTER INTERNATIONAL INC.Set administration intravascularPotential harm to a health care provider;Serious injury2024-03-28Leaky Baxter tubing - lot number R23A10154. Alcohol-impregnated caps have been placed on the y-sites of the tubing that have been leaking in our units. TPN running and leaking outside of the green alcohol cap. Manufacturer response for IV Tubing - (brand not provided) (per site reporter) Weekly meetings with [redacted name] and neonatal ICU teams as well now. They have offered a substitute product due to increasing number of leaks in our 2R8546 model.
L-Cath™ S/L PICC S/LARGON MEDICAL DEVICES INC.CatheterIntravascularTherapeuticLong-Term Greater Than 30 DaysNot applicable2024-03-28Registered Nurse Transport Specialist (RNTS) called to bedside to remove 1.9Fr peripherally inserted central catheter (PICC) line. Line inserted at the ankle saphenous vein of the right leg. RNTS confirmed the PICC removal order. RNTS stopped IVF once at bedside and dressing removed using adhesive remover. Placing a small Chloroprep wand over the insertion site - RNTS began to slowly pull back on the PICC line. Several centimeters were easily pulled back. RNTS noted that line did not full remove and attempted to pull line out again. PICC line snapped near insertion site. RNTS held fingers tightly around leg to act as a tourniquet. RNTS removed Chloroprep wand slowly to reveal <0.25cm of PICC line out of insertion site. RNTS attempted to grab end using forceps but line slipped beneath skin at insertion site. Bedside RN immediately notified NNP (Neonatal Nurse Practitioner) who came to bedside and ordered stat x-rays. Tibia/Fibula (Tib-Fib) and kidney - ureter - and bladder (KUB) x-ray done to show PICC line between knee and pelvis. Approximately 10cm of line remains. Per the advise of VAD (Vascular Access Department) - a loose tourniquet was placed around the patients thigh to help hold line in place. RNTS applied light band without compromising perfusion to leg. NNP reached out to IR (Interventional radiology). During removal - PICC line snapped only allowing half of the line to be removed. With 7cm of the line remaining in patient requiring IR removal under anesthesia. Neonatal team have reached out to Argon directly to identify any issues with their product as this seems to be a trend with their PICC lines. Removed portion of PICC line in RNTS office - remainder was discarded. This event was reported to CDPH as retention of a foreign object following surgery or procedure.
ARROWTELEFLEX INCORPORATEDCatheter percutaneousSerious injury2024-03-27This patient had known - severe calcification of the femoral arteries. On a recent catheterization - sheath removal was also complex. The interventional team elected to use the Arrow braided sheath to reinforce the stability and integrity of the access for this procedure - which was appropriate. The team was at the bedside removing the femoral sheath when a unique situation transpired - where the sheath hub detached from the shaft of the sheath. The shaft of the sheath remained in the patient and the patient began to lose blood in a pulsatile fashion from this location. Pressure was held. The patient briefly became unresponsive and was given 1 amp Epinephrine. Vascular surgery was called to the bedside and was able to retrieve the sheath. Manual pressure was held for approximately 40 minutes. The patient was given 2 units of PRBCs and was started on Levophed. The patient was transferred to the CCU for close monitoring. We have not previously seen this situation occur at MGH - and it clearly represents a manufacturing fallibility in the sheath - rather than a user error or inappropriate usage. The team removing the sheath is very experienced in sheath removal.
Linear 7.5Fr. 34cc IAB with Accessories US OnlyDATASCOPE CORP.System Balloon Intra-Aortic And ControlSerious injury2024-03-26Blood was noted in left axillary intra-aortic balloon pump (IABP) helium sheath after patient turned onto her left side. Blood found in the balloon. Immediate pain and paresthesia to left lower extremity - Vascular Surgery consulted - patient went to the Operating Room for left axillary artery repair and hematoma removal.
OCS Heart SystemTRANSMEDICS INC.Organ Care System (Ocs) Heart SystemPotential for patient harm2024-03-26A donor heart was accepted for a hospital recipient. The transplant team used TransMedics Heart Organ Care System (OCS) to procure the heart. The heart procurement proceeded as normal however - it was noted that the compliance chamber of the TransMedics Heart OCS was getting larger than normal when they were priming the system. There was also a persistent air bubble that appeared next to the blood warmer. As a result - the heart could not be placed on the TransMedics Organ Care System and therefore the heart was rendered unusable for transplant due to the inability to be perfuse on the TransMedics device. This event did not cause death nor serious injury as the recipient remained on the heart transplant wait-list and was transplanted later - with a different organ. However - it rendered a heart that would have been used for transplant - unusable. The transplant team worked with TransMedics to understand the root cause of the problem and it was noted that there was a kink in the pulmonary artery (PA) tubing causing the aforementioned issues. ====================== Manufacturer response for Organ Care System - TransMedics Heart Organ Care System (per site reporter) ====================== Per TransMedics representative - they have identified the failure mode and have planned design modifications as a corrective action. The perfusion module was returned to TransMedics. Inspection of the returned perfusion module noted there was a kink in the PA (Pulmonary Artery) tubing line. The module was filled with water and was cycled. The engorged compliance chamber and air bubble near the blood warmer were replicated. When the kink in the PA tubing line was relieved - the air bubble was able to pass and the compliance chamber returned to a normal volume. Based on our analysis - we concluded that the direct root cause of the observed problems was due to the kink in the PA tubing. We are still investigating the underlying cause of the kink.
Philips PIIC IX Rev C PIIC IX Rev 4Philips North America LLCMONITOR PHYSIOLOGICAL PATIENT(WITH ARRHYTHMIA DETECTION OR ALARMS)Potential for patient harm2024-03-22UPS (uninterruptible power supply) which are located in data closets that power central patient monitoring have failed across the Hospital. These failures have impacted patient care by the loss of central monitoring across multiple critical care floors. The hospital is reporting 14 failures out of approximately 22 units that were placed into the [redacted name] building within the past 10 months. These UPS devices are under warranty and are manufactured by Schneider while being distributed by Philips Healthcare. They were placed into service using the same purchase order and ordering date. [redacted name] has engaged Philips and they have replaced each UPS under the 1 year warranty - however - [redacted name] has requested that Philips Healthcare proactively replace the UPS units before failure. Philips has not acted upon the request and would prefer that the UPS units first fail before being replaced. UPDATE [redacted date] Since the original submission - 1 UPS failure occurred on the weekend of [redacted date] which took out all patient monitoring on [redacted name] North and South. Another 1 UPS failure occurred on [redacted date] which took out all patient monitoring on [redacted name] North and South. The hospital still has a UPS failure occurring - on average - every 3 weeks. The hospital expects this rate to continue until all affected units are replaced. The direct result of this is a systemic continued loss of all patient monitoring across inpatient and ICU floors. UPDATE [redacted date] Philips was onsite on [redacted date] and during their field work - there was another UPS failure that was located on one of [redacted name] 3's distribution pairs. The redundancy to the distribution pairs allowed for no loss of patient monitoring. Also - due to redundancy of distribution pairs - unable to determine when the unit specifically failed. Biomed identifying stickers indicate this unit went into use [redacted date].
Philips PIIC IX Rev C PIIC IX Rev 4Philips North America LLCMONITOR PHYSIOLOGICAL PATIENT(WITH ARRHYTHMIA DETECTION OR ALARMS)Potential for patient harm2024-03-21UPS (uninterruptible power supply) which are located in data closets that power central patient monitoring have failed across the Hospital. These failures have impacted patient care by the loss of central monitoring across multiple critical care floors. The hospital is reporting 14 failures out of approximately 22 units that were placed into the [redacted name] building within the past 10 months. These UPS devices are under warranty and are manufactured by Schneider while being distributed by Philips Healthcare. They were placed into service using the same purchase order and ordering date. [redacted name] has engaged Philips and they have replaced each UPS under the 1 year warranty - however - [redacted name] has requested that Philips Healthcare proactively replace the UPS units before failure. Philips has not acted upon the request and would prefer that the UPS units first fail before being replaced. UPDATE [redacted date] Since the original submission - 1 UPS failure occurred on the weekend of [redacted date] which took out all patient monitoring on [redacted name] North and South. Another 1 UPS failure occurred on [redacted date] which took out all patient monitoring on [redacted name] North and South. The hospital still has a UPS failure occurring - on average - every 3 weeks. The hospital expects this rate to continue until all affected units are replaced. The direct result of this is a systemic continued loss of all patient monitoring across inpatient and ICU floors.